PNAS 2013-09-03

Axial interactions in the mixed-valent CuA active site and role of the axial methionine in electron transfer.

Ming-Li Tsai, Ryan G Hadt, Nicholas M Marshall, Tiffany D Wilson, Yi Lu, Edward I Solomon

Index: Proc. Natl. Acad. Sci. U. S. A. 110(36) , 14658-63, (2013)

Full Text: HTML

Abstract

Within Cu-containing electron transfer active sites, the role of the axial ligand in type 1 sites is well defined, yet its role in the binuclear mixed-valent CuA sites is less clear. Recently, the mutation of the axial Met to Leu in a CuA site engineered into azurin (CuA Az) was found to have a limited effect on E(0) relative to this mutation in blue copper (BC). Detailed low-temperature absorption and magnetic circular dichroism, resonance Raman, and electron paramagnetic resonance studies on CuA Az (WT) and its M123X (X = Q, L, H) axial ligand variants indicated stronger axial ligation in M123L/H. Spectroscopically validated density functional theory calculations show that the smaller ΔE(0) is attributed to H2O coordination to the Cu center in the M123L mutant in CuA but not in the equivalent BC variant. The comparable stabilization energy of the oxidized over the reduced state in CuA and BC (CuA ∼ 180 mV; BC ∼ 250 mV) indicates that the S(Met) influences E(0) similarly in both. Electron delocalization over two Cu centers in CuA was found to minimize the Jahn-Teller distortion induced by the axial Met ligand and lower the inner-sphere reorganization energy. The Cu-S(Met) bond in oxidized CuA is weak (5.2 kcal/mol) but energetically similar to that of BC, which demonstrates that the protein matrix also serves an entatic role in keeping the Met bound to the active site to tune down E(0) while maintaining a low reorganization energy required for rapid electron transfer under physiological conditions.


Related Compounds

Related Articles:

Understanding the mechanism of short-range electron transfer using an immobilized cupredoxin.

2012-07-25

[J. Am. Chem. Soc. 134(29) , 11848-51, (2012)]

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.

2013-03-19

[Br. J. Cancer 108(5) , 1061-70, (2013)]

Structural and functional effects of Cu metalloprotein-driven silver nanoparticle dissolution.

2012-06-05

[Environ. Sci. Technol. 46(11) , 6355-62, (2012)]

Effects of the protein environment on the spectral properties of tryptophan radicals in Pseudomonas aeruginosa azurin.

2013-03-27

[J. Am. Chem. Soc. 135(12) , 4822-33, (2013)]

Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.

2012-11-01

[Appl. Environ. Microbiol. 78(21) , 7603-10, (2012)]

More Articles...